|
Volumn 20, Issue 3-4, 2001, Pages 526-531
|
Modeling the economic benefits of an AIDS vaccine
|
Author keywords
AIDS; Costs; Demand; Economics; Epidemiology; HIV; Vaccine
|
Indexed keywords
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ARTICLE;
COST BENEFIT ANALYSIS;
DEVELOPED COUNTRY;
HEALTH CARE COST;
INFECTION RISK;
POVERTY;
PRIORITY JOURNAL;
PRODUCTIVITY;
PROPHYLAXIS;
PUBLIC HEALTH;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ADOLESCENT;
ADULT;
AIDS VACCINES;
CHILD;
CHILD, PRESCHOOL;
HUMANS;
INFANT;
INFANT, NEWBORN;
MALE;
MIDDLE AGED;
MODELS, ECONOMIC;
PUBLIC HEALTH;
|
EID: 0035851351
PISSN: 0264410X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0264-410X(01)00335-8 Document Type: Article |
Times cited : (10)
|
References (12)
|